Patents
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
01/2011
01/12/2011CN101157691B Production technique of hydrochloric acid palonosetron
01/06/2011WO2011001400A2 Processes for the preparation of form i and form ii of palonosetron hydrochloride
01/06/2011US20110003849 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
01/06/2011US20110003802 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase
01/06/2011US20110003799 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
01/05/2011EP2270114A1 Photobase generator
01/05/2011CN101939311A Heterocyclic compounds with affinity to muscarinic receptors
01/04/2011US7863271 2-aminobenzoxazole carboxamides as 5HT3 modulators
12/2010
12/29/2010EP1776360B1 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases.
12/29/2010EP1001946B1 QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/23/2010US20100324085 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
12/23/2010US20100324025 Antibacterial Agents
12/22/2010CN101925600A Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester
12/16/2010WO2010144043A1 A novel 4-methylbenzenesulphonate salt and a process for preparing a pharmaceutical composition comprising the salt
12/16/2010US20100317842 Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry
12/15/2010CN101913973A Preparation and use of alkylating agents
12/08/2010EP2258682A2 Amino-substituted tricyclic derivatives and methods of use
12/08/2010EP1781290B1 Anti-inflammatory agents
12/08/2010CN101910170A (1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease
12/01/2010EP2256117A1 Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists
12/01/2010EP2256106A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
11/2010
11/30/2010US7842687 Cephalotaxane derivatives and their processes of preparation and purification
11/25/2010US20100298371 Process for preparing chemically and chirally pure solifenacin base and its salts
11/24/2010EP2253631A1 Spyrocyclic quiniclidinic ether derivatives
11/24/2010EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer
11/23/2010US7838527 Methods of treating cancer and related methods
11/23/2010CA2423192C 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
11/18/2010WO2010131145A1 Cyclobutenedione derivatives
11/18/2010US20100292267 Palonosetron free base and process for its preparation
11/11/2010US20100286195 Novel benzooxazol-and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/10/2010CN1980889B Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/10/2010CN101883771A Quinuclidin-4-ylmethyl 1H-indole-3-carboxylate derivatives as alpha 7 nicotinic acetylcholine receptor ligands for the treatment of alzheimer's disease
11/09/2010US7829715 reacting succinic acid with solifenacin to form solifenacin succinate; treating urinary incontinence, overactive bladder, urogenital disorders
11/09/2010US7829583 Biphenyl derivatives
11/09/2010CA2496164C Benzimidazole quinolinones and uses thereof
11/03/2010EP2246345A1 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/02/2010US7825140 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
10/2010
10/28/2010WO2010121963A1 Resorcinol derivatives as hsp90 inhibitors
10/28/2010WO2009139002A3 An improved process for the preparation of solifenacin and its pharmaceutically acceptable salts thereof
10/27/2010CN101869846A Catalyst of first category bi-quinine or bi-quinidine, synthesis method and application
10/26/2010CA2457053C Preventive agent/remedial agent for constipation predominant ibs
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/13/2010CN1886362B Preparation and use of alkylating agents
10/13/2010CN101857593A 9-amino quinine derivative and 9-amino-cinchonidine derivative and synthetic method thereof
10/13/2010CN101255157B Crystal system of chlorhydric acid palonosetron and preparation method thereof
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010CA2757188A1 Pyrimidine compound
10/06/2010EP1633752B1 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
10/06/2010CN101851233A Palonosetron hydrochloride, and precursor compound and preparation method thereof
10/06/2010CN101402634B Separation and purification process for alkaloid in cinchona bark
09/2010
09/30/2010US20100249420 Process for preparing quinuclidinium carbamate derivatives
09/29/2010EP2231658A2 Palonosetron free base and process for its preparation
09/29/2010EP1727817B1 Azabicyclooctan-3-one derivatives and use thereof
09/29/2010EP1615889B1 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
09/28/2010US7803792 benzothiazepine compounds having a thioamide bond and a quaternary ammonium substituent, exhibiti a potent ileal bile acid transporter inhibiting activity, used for for treating hyperlipidemia or arteriosclerosis
09/23/2010US20100240696 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
09/22/2010EP2229387A1 Process for preparing chemically and chirally pure solifenacin base and its salts
09/22/2010EP2229374A1 Amido-thiophene compounds and their use as 11-beta-hsd1 inhibitors
09/16/2010WO2010103529A1 A new method for the preparation of solifenacin and new intermediate thereof
09/16/2010US20100234591 Biaryl heterocyclic compounds and methods of making and using the same
09/16/2010US20100234354 Pyridazinone derivatives
09/16/2010US20100234333 Novel quinuclidine derivatives and medicinal compositions containing the same
09/16/2010US20100234332 Novel quinuclidine derivatives and medicinal compositions containing the same
09/15/2010EP1811999B1 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
09/15/2010CN101830896A Organic acid salt of optical isomer of penehyclidine
09/14/2010US7795453 6-[(Anilinocarbonyl)amino]-N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-1-benzothiophene-2-carboxamide hydrochloride; treatment of dementia, attention deficit hyperactivity disorder and impairments of learning and memory
09/14/2010US7795272 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
09/08/2010CN1732154B Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
09/08/2010CN101824033A Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
09/07/2010CA2492081C Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
09/02/2010US20100222378 2-heteroarylcarboxylic acid amides
09/02/2010US20100222361 2-acylaminothiazole derivative or salt thereof
09/02/2010US20100222329 2-acylaminothiazole derivative or salt thereof
08/2010
08/31/2010US7786162 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
08/26/2010WO2010094210A1 Preparation method of (4s,5r)-half-ester
08/25/2010EP2220082A2 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
08/25/2010EP1517892B1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
08/25/2010CN101054375B Compound capable of inhibiting tubercle bacillus growth and application thereof
08/24/2010US7781430 Benzoxazole carboxamides for treating CINV and IBS-D
08/19/2010WO2010092153A1 New substituted tetrahydronapthalenes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010056656A3 Preparation of crystalline palonosetron hydrochloride
08/19/2010WO2009122034A8 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
08/18/2010EP2217597A1 Quinuclidin-4-ylmethyl 1h-indole-3-carboxylate derivatives as alpha 7 nicotinic acetylcholine receptor ligands for the treatment of alzheimer's disease
08/18/2010EP1874761B1 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors
08/18/2010EP1737842B1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
08/17/2010US7776879 anticholinergic agents such as Butylthiophen-2-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester, having a high affinity for muscarinic M3 receptors, useful for treating respiratory system, urogenital, gastrointestinal and cardiovascular disorders
08/17/2010US7776309 Such as fluoromethyl-tyrosine and/or N,N-methyl-N-fluoromethylethanolamine
08/12/2010WO2010091164A1 Inhibitors of glucosylceramide synthase
08/11/2010EP1537099B1 Pyrrole based inhibitors of glycogen synthase kinase 3
08/11/2010CN101801950A Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
08/11/2010CN101797519A Application of fluoro-diphenyl sulfimide as nitrogen heterocyclic Diels-Alder reaction catalyst
08/05/2010WO2010012459A3 A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
08/05/2010US20100197662 Heterocyclic compound having type i 11 beta hydroxysteroid dehydrogenase inhibitory activity
08/05/2010US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase
08/04/2010CN101796050A Process for production of optically active 3-quinuclidinol derivative
08/04/2010CN101792441A Crystal forms of palonosetron hydrochloride and preparation method thereof
08/03/2010US7767811 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 58